Loading clinical trials...
Loading clinical trials...
This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of IgPro20 (subcutaneous Ig) treatment in adult subjects with dermatomyositis (DM). The primary objective of this stu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CSL Behring
NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more
NCT00017914 · Dermatomyositis, Polymyositis, and more
NCT07089121 · Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT07160205 · Idiopathic Inflammatory Myositis (IIM), DERMATOMYOSITIS OR POLYMYOSITIS
8401117 - Arizona Arthritis & Rheumatology Research
Glendale, Arizona
8401199 - Neuromuscular Research Center
Phoenix, Arizona
8401129 - UCLA - Rheumatology Los Angeles
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions